The effect of gefinitb (Iressa) on radiation of lung-analysis of anti-cancer effect and radiation pneumonia

吉非替尼(易瑞沙)对肺部辐射的影响——抗癌作用及放射性肺炎分析

基本信息

  • 批准号:
    15591262
  • 负责人:
  • 金额:
    $ 2.37万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2003
  • 资助国家:
    日本
  • 起止时间:
    2003 至 2006
  • 项目状态:
    已结题

项目摘要

We conducted the respiratory function determination, pulmonary function determination, blood biochemistry and histological study in irradiated rats, and studied the effect of irradiation on their respiratory and pulmonary functions.Rats were divided into the following four groups; 25Gy left lung irradiation group, 17Gy bilateral lung irradiation group, 20Gy bilateral lung irradiation group and 25Gy bilateral lung irradiation group. The rats, having had their lungs irradiated in the Yamanashi University School of Medicine, were accepted in this research institute. We determined the body weight, body temperature and respiratory function every week and conducted pulmonary function determination, measurement of differential leukocyte counts of bronchoalveolar lavage fluid (BALF), arterial blood gas analysis, hematology, blood biochemistry and histopathological study every two weeks.Based on the results, changes in respiratory function, pulmonary function, hematological parameters, differen … More tial leukocyte counts of BALF and pulmonary fibrosis were confirmed following the irradiation of lungs in rats. To study the therapeutic effect of drugs on these irradiation-linked changes, a study conducted 6-8 weeks after irradiation including the 20Gy bilateral lung irradiation group, among the 25Gy left lung irradiation, 17Gy bilateral lung irradiation, 20Gy bilateral lung irradiation, and 25Gy bilateral lung irradiation groups, may be suitable.Next, we administrated 5 days of gefinitib(50mg/kg/body weight) and/or once cisplatin(10mg/kg/body weight) just before irradiation of 20Gy for bilateral rat lungs. The lung inflammation and fibrosis was increased by the administration of gefinitib and more by the addition of cisplatin in the findings of physiological pulmonary function and histopathology.In conclusion, a study conducted 6-8 weeks after irradiation including the 20Gy bilateral lung irradiation is a good model for a evaluation of a drug effect on rat radiation lung interstitial change, and we have to pay attention to the addition of gefinitib and/or cisplatin to lung radiotherapy. Less
本实验将大鼠随机分为4组:25 Gy左肺照射组、17 Gy双肺照射组、20 Gy双肺照射组和25 Gy双肺照射组,分别进行呼吸功能、肺功能测定、血液生化和组织学检查,研究照射对大鼠呼吸功能和肺功能的影响。在山梨大学医学院接受肺部照射的大鼠被该研究所接受。每周测定体重、体温和呼吸功能,每2周进行肺功能测定、支气管肺泡灌洗液(BALF)白细胞分类计数、动脉血气分析、血液学、血液生化学和组织病理学检查,根据结果观察呼吸功能、肺功能、血液学指标、肺组织病理学变化,并与对照组比较。 ...更多信息 大鼠肺照射后BALF中白细胞计数下降,肺纤维化。为了研究药物对这些放射相关变化的治疗作用,在25 Gy左肺照射组、17 Gy双肺照射组、20 Gy双肺照射组和25 Gy双肺照射组中,在照射后6-8周进行包括20 Gy双肺照射组的研究可能是合适的。在20 Gy照射大鼠双侧肺前给予吉非替布(50 mg/kg/体重)和/或顺铂(10 mg/kg/体重)1次。在生理肺功能和组织病理学的发现中,给予吉非替布增加了肺炎症和纤维化,并且加入顺铂增加了更多。总之,在照射后6-8周进行的研究,包括20 Gy的双侧肺照射,是评价药物对大鼠放射性肺间质变化的作用的良好模型,在肺放疗中应注意吉非替尼和/或顺铂的联合应用。少

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ONISHI Hiroshi其他文献

ONISHI Hiroshi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ONISHI Hiroshi', 18)}}的其他基金

A Study of Investigating and Revitalizing the Japanese Art Market
日本艺术市场调查与振兴研究
  • 批准号:
    16H07228
  • 财政年份:
    2016
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Effect and safety of stereotactic radiotherapy for cancers in various organs except for lung and liver
立体定向放射治疗除肺、肝癌外各脏器肿瘤的疗效及安全性
  • 批准号:
    16H05389
  • 财政年份:
    2016
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Occurrence mechanism of horizontal cracks in RC decks.
RC桥面板水平裂缝的发生机理
  • 批准号:
    24560581
  • 财政年份:
    2012
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Electronic excited states in photocatalysts observed with Raman spectroscopy
用拉曼光谱观察光催化剂中的电子激发态
  • 批准号:
    24655014
  • 财政年份:
    2012
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Visible-light sensitized photocatalysts characterized by resonance Raman spectroscopy
通过共振拉曼光谱表征可见光敏化光催化剂
  • 批准号:
    21360395
  • 财政年份:
    2009
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Basic study on foreigner's communities in port cities and international exchange of modern Japan
近代日本港口城市外国人社区与国际交流的基础研究
  • 批准号:
    18520518
  • 财政年份:
    2006
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Study of Sesshu based both on his works and documentary sources around him
对雪舟的研究基于他的作品和他周围的文献资料
  • 批准号:
    15520095
  • 财政年份:
    2003
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Infrared-based and Raman-based Observation of Molecular Vibrations towards Physicochemical Analysis of Ionic Liquids
基于红外和拉曼的分子振动观察对离子液体的物理化学分析
  • 批准号:
    14340190
  • 财政年份:
    2002
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
A Study of Medieval and Early Modern Orihon-gajo, or Album Picture, Focusing on its Function as a Medium
中世纪和近代早期专辑图片研究,重点关注其作为媒介的功能
  • 批准号:
    10610065
  • 财政年份:
    1998
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A Study of the interactive relationship between the creation and reception of literary texts
文学文本创作与接受的互动关系研究
  • 批准号:
    07451093
  • 财政年份:
    1995
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似海外基金

Elucidation of the mechanism of radiation pneumonitis severity caused by Clonal Hematopoiesis.
阐明克隆性造血引起放射性肺炎严重程度的机制。
  • 批准号:
    23K07108
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Establishment of radiotherapy technique to minimise the risk of radiation pneumonitis in locally advanced non-small cell lung cancer.
建立放射治疗技术,以尽量减少局部晚期非小细胞肺癌发生放射性肺炎的风险。
  • 批准号:
    22K20856
  • 财政年份:
    2022
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
The research for the pathogenesis of radiation pneumonitis to develop new treatment to supplement glucocorticosteroid
放射性肺炎发病机制研究开发新疗法补充糖皮质激素
  • 批准号:
    21K08212
  • 财政年份:
    2021
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of BIO 300 for mitigation and/or treatment of radiation pneumonitis and fibrosis
开发用于缓解和/或治疗放射性肺炎和纤维化的 BIO 300
  • 批准号:
    10401463
  • 财政年份:
    2020
  • 资助金额:
    $ 2.37万
  • 项目类别:
eNamptorTM: A Humanized mAb To Reduce the Severity of Radiation Pneumonitis and Fibrosis
eNamptorTM:一种降低放射性肺炎和纤维化严重程度的人源化单克隆抗体
  • 批准号:
    10011266
  • 财政年份:
    2020
  • 资助金额:
    $ 2.37万
  • 项目类别:
Development of BIO 300 for mitigation and/or treatment of radiation pneumonitis and fibrosis
开发用于缓解和/或治疗放射性肺炎和纤维化的 BIO 300
  • 批准号:
    10845829
  • 财政年份:
    2020
  • 资助金额:
    $ 2.37万
  • 项目类别:
Development of objective evaluation method for radiation pneumonitis
放射性肺炎客观评价方法的建立
  • 批准号:
    20K08034
  • 财政年份:
    2020
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
eNamptorTM: A Humanized mAb To Reduce the Severity of Radiation Pneumonitis and Fibrosis
eNamptorTM:一种降低放射性肺炎和纤维化严重程度的人源化单克隆抗体
  • 批准号:
    10415224
  • 财政年份:
    2020
  • 资助金额:
    $ 2.37万
  • 项目类别:
eNamptorTM: A Humanized mAb To Reduce the Severity of Radiation Pneumonitis and Fibrosis
eNamptorTM:一种降低放射性肺炎和纤维化严重程度的人源化单克隆抗体
  • 批准号:
    10274779
  • 财政年份:
    2020
  • 资助金额:
    $ 2.37万
  • 项目类别:
Development of BIO 300 for mitigation and/or treatment of radiation pneumonitis and fibrosis
开发用于缓解和/或治疗放射性肺炎和纤维化的 BIO 300
  • 批准号:
    10194370
  • 财政年份:
    2020
  • 资助金额:
    $ 2.37万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了